1. European Urology Oncology
Validation of the Decipher Test for Predicting Distant Metastatic Recurrence in Men with High-risk Nonmetastatic Prostate Cancer 10 Years After Surgery 
Thomas Van den Broeck, Lisa Moris, Thomas Gevaert, Lorenzo Tosco, Elien Smeets, Nick Fishbane, Yang Liu, Christine Helsen, Jennifer Margrave, Christine Buerki, Elai Davicioni, Hendrik Van Poppel, Wouter Everaerts, Sheila Weinmann, Robert Den, John Davis, Edward Schaeffer, R. Jeffrey Karnes, Frank Claessens, Steven Joniau 
European Urology Oncology 
DOI: /j.euo
Copyright © Terms and Conditions

2. Fig. 1
CONSORT diagram showing the study design and the patient selection process for the Leuven cohort. Bx=biopsy; EAU=European Association of Urology; PC=prostate cancer; PLND=pelvic lymph node dissection; PSA=prostate-specific antigen.
European Urology Oncology DOI: ( /j.euo )
Copyright © Terms and Conditions

3. Fig. 2
Decipher score distribution plots. (A) Decipher score distributions among cases and controls. Horizontal lines denote the median scores and interquartile range. Whiskers of the boxplot represent all of the values included. Dashed lines represent the cut points for the Decipher risk groups. (B) Decipher risk-group distributions among cases and controls.
European Urology Oncology DOI: ( /j.euo )
Copyright © Terms and Conditions

4. Fig. 3
Cumulative incidence analysis: incidence of metastatic recurrence stratified according to Decipher score groups. Time from radical prostatectomy (RP) to distant metastases (Mets), with time zero representing the date of surgery.
European Urology Oncology DOI: ( /j.euo )
Copyright © Terms and Conditions

5. European Urology Oncology DOI: (10.1016/j.euo.2018.12.007)
Copyright © Terms and Conditions

6. European Urology Oncology DOI: (10.1016/j.euo.2018.12.007)
Copyright © Terms and Conditions